Modified FOLFIRI as Second-Line Chemotherapy after Failure of Modified FOLFOX-4 in Advanced Gastric Cancer

机译：改良FOLFFIRI作为晚期胃癌改良FOLFOX-4失败后的二线化疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

PurposeThe purpose of this study was to evaluate efficacy and toxicity of irinotecan, leucovorin and 5-fluorouracil (FOLFIRI) as second-line treatment after failure of oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) for advanced gastric cancer.

机译：目的本研究的目的是评估伊立替康，亚叶酸和5-氟尿嘧啶（FOLFIRI）作为奥沙利铂，亚叶酸和5-氟尿嘧啶（FOLFOX）治疗晚期胃癌失败的二线治疗的疗效和毒性。

著录项

期刊名称 Cancer Research and Treatment : Official Journal of Korean Cancer Association
作者
Eun Kyoung Jeon; Sook Hee Hong; Tae Hee Kim; Seung Eun Jung; Ji Chan Park; Hye-Sung Won; Yoon-Ho Ko; Sang Young Rho; Young Seon Hong;
展开▼
作者单位

展开▼
年(卷),期 2011(43),3
年度 2011
页码 148–153
总页数 6
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Stomach neoplasms Chemotherapy FOLFIRI;

机译：胃肿瘤;化学疗法;FOLFIRI;

相似文献

外文文献
中文文献
专利

1. Biweekly oxaliplatin in combination with continuous infusional 5-fluorouracil and leucovorin (modified FOLFOX-4 regimen) as first-line chemotherapy for elderly patients with advanced gastric cancer. [J] . Liu ZF, Guo QS, Zhang XQ, American Journal of Clinical Oncology: Cancer Clinical Trials . 2008,第3期

机译：每两周一次奥沙利铂联合连续输注5-氟尿嘧啶和亚叶酸（改良的FOLFOX-4方案）作为老年晚期胃癌患者的一线化疗。
2. Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimen [J] . Sendur Mehmet Ali Nahit, Ozdemir Nuriye, Ozatli Tahsin, Medical oncology . 2014,第9期

机译：比较二线改良EOX（依匹比星，奥沙利铂和卡培他滨）与伊立替康，5-氟尿嘧啶和亚叶酸（FOLFIRI）方案在转移性胃癌患者中的疗效，这些患者在一线改良多西紫杉醇和顺铂加氟尿嘧啶（DCF）的基础上进展养生
3. A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer [J] . C Yoo, J Y Hwang, J-E Kim, British Journal of Cancer . 2009,第10期

机译：吉西他滨难治性晚期胰腺癌改良FOLFIRI.3与改良FOLFOX作为二线治疗的随机II期研究
4. Efficacy of combination chemotherapy with docetaxel and irinotecan as first- or second-line treatment for advanced gastric cancer [C] . K. Sugiyama, A. Ishikawa, T. Watanabe International Gastric Cancer Congress . 2009

机译：组合化疗与多西紫杉醇和伊替康的疗效，作为晚期胃癌的第一或二线治疗
5. Treatment Patterns and Cost-Effectiveness of Chemotherapy Treatments among Advanced Gastric Cancer Patients [D] . Haag, Austin Jade. 2017

机译：晚期胃癌患者化学疗法的治疗模式和成本效益
6. A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer [O] . C Yoo, J Y Hwang, J-E Kim, 2009

机译：改良的FOLFIRI.3与改良的FOLFOX作为二线治疗吉西他滨难治性晚期胰腺癌的随机II期研究
7. Modified FOLFIRI as Second-Line Chemotherapy after Failure of Modified FOLFOX-4 in Advanced Gastric Cancer [O] . Jeon, Eun Kyoung, Hong, Sook Hee, Kim, Tae Hee, 2011

机译：改良FOLFFIRI作为晚期胃癌改良FOLFOX-4失败后的二线化疗

Modified FOLFIRI as Second-Line Chemotherapy after Failure of Modified FOLFOX-4 in Advanced Gastric Cancer

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅